Table 2 Characteristics of the study participants grouped by with and without hyperhomocysteinemia
Variables | Total (n = 1018) | Normal Hcy (n = 601) | HHcy (n = 417) | p |
|---|---|---|---|---|
Male, n (%) | 521 (51.2) | 271 (45.1) | 250 (60) | < 0.001 |
Age, | 59.9 ± 13.1 | 56.0 ± 13.5 | 65.5 ± 10.0 | < 0.001 |
Race, n (%) | < 0.001 | |||
Mexican American | 290 (28.5) | 194 (32.3) | 96 (23) | |
Other Hispanic | 30 (2.9) | 27 (4.5) | 3 (0.7) | |
Non-Hispanic White | 378 (37.1) | 202 (33.6) | 176 (42.2) | |
Non-Hispanic Black | 278 (27.3) | 148 (24.6) | 130 (31.2) | |
Other Race | 42 (4.1) | 30 (5) | 12 (2.9) | |
HbA1c, % | 7.5 ± 1.8 | 7.6 ± 1.9 | 7.2 ± 1.6 | < 0.001 |
ALB, g/L | 40.7 ± 3.7 | 41.0 ± 3.3 | 40.4 ± 4.1 | 0.023 |
BUN, mmol/L | 5.6 ± 3.2 | 4.6 ± 1.5 | 7.2 ± 4.1 | < 0.001 |
Scr, μmol/L | 91.3 ± 55.1 | 74.3 ± 18.6 | 116.0 ± 76.9 | < 0.001 |
eGFR, ml/min/1.73 m2 | 82.4 ± 39.6 | 94.3 ± 35.1 | 69.0 ± 40.1 | < 0.001 |
ACR, g/mmol | 1.6 (0.8, 5.1) | 1.3 (0.7, 3.6) | 2.5 (1.0, 10.1) | < 0.001 |
CHO, mmol/L | 5.2 ± 1.3 | 5.3 ± 1.3 | 5.0 ± 1.3 | 0.002 |
TG, mmol/L | 2.2 ± 2.1 | 2.2 ± 2.2 | 2.2 ± 1.9 | 0.671 |
UA, μmol/L | 334.2 ± 94.3 | 306.9 ± 79.1 | 373.5 ± 100.4 | < 0.001 |